Przejdź do zawartości
Merck

Przejdź do

T9652

Terfenadine

≥97.5% (HPLC), powder, H1 histamine receptor antagonist

Synonim(y):

α-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Gabaryty przesyłkiSKUDostępnośćCena netto
5 g
Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności
455,00 zł
25 g
Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności
1810,00 zł

Informacje o tej pozycji

Wzór empiryczny (zapis Hilla):
C32H41NO2
Numer CAS:
Masa cząsteczkowa:
471.67
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12161501
EC Number:
256-710-8
MDL number:
Quality level:

455,00 zł


Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności

Zamów zamówienie zbiorcze
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


Nazwa produktu

Terfenadine,

Quality Level

solubility

chloroform: soluble 250 mg plus 5 ml of solvent, clear to very slightly hazy, colorless to faintly yellow, H2O: soluble 0.01 mg/mL at 30 °C, 1 M HCl: soluble 0.12 mg/mL at 30 °C, hexane: soluble 0.34 mg/mL at 30 °C, 0.1 M tartaric acid: soluble 0.45 mg/mL, 0.1 M citric acid: soluble 1.1 mg/mL, methanol: soluble 37.5 mg/mL at 30 °C, ethanol: soluble in salt form 37.8 mg/mL at 30 °C

originator

Sanofi Aventis

storage temp.

2-8°C

SMILES string

CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4

InChI

1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3

InChI key

GUGOEEXESWIERI-UHFFFAOYSA-N

Application

Terfenadine has been used to study the role of histamine in itch related to proteinase-activated receptors (PARs) in mice[1]. Terfenadine has also been used to block histamine receptor type 1 to study the pathogenesis of 2,4-dinitrobenzene sulfonic acid (DNBS)-induced ulcerative colitis in rats[2].
Terfenadine has been used as a positive control in electrophysiology recordings. It has also been used as a constituent of internal standard solution in liquid chromatography-mass spectrometry (LC-MS).[3]

Biochem/physiol Actions

Non-sedating second generation H1 histamine receptor antagonist.
Non-sedating second generation H1 histamine receptor antagonist. Mainly metabolized by Cyp3A4, 5, 7. Inhibits CYP2C8.
Terfenadine acts a potential anti-histamine and is used in the treatment of allergic rhinitis and chronic urticaria.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Preparation Note

250 mg of Terfenadine dissolves in 5ml of chloroform to yield a clear, colorless solution. Terfenadine is also soluble at 30° C in 0.1 M citric acid (1.1 mg/ml), water (0.01 mg/ml), methanol (37.5 mg/ml), hexane (0.34 mg/ml), ethanol (37.8 mg/ml), 1 M hydrochloric acid (0.12 mg/ml), and 0.1 M tartaric acid (0.45 mg/ml).
Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
T4182T5648G0544
Quality Level

200

Quality Level

100

Quality Level

-

Quality Level

100

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

solubility

chloroform: soluble 250 mg plus 5 ml of solvent, clear to very slightly hazy, colorless to faintly yellow, 1 M HCl: soluble 0.12 mg/mL at 30 °C, 0.1 M tartaric acid: soluble 0.45 mg/mL, methanol: soluble 37.5 mg/mL at 30 °C, H2O: soluble 0.01 mg/mL at 30 °C, 0.1 M citric acid: soluble 1.1 mg/mL, hexane: soluble 0.34 mg/mL at 30 °C, ethanol: soluble in salt form 37.8 mg/mL at 30 °C

solubility

0.1 M HCl: soluble <0.4 mg/mL, DMSO:methanol (1:1): soluble 10 mg/mL, clear, colorless, ethanol: soluble 10 mg/mL, methylene chloride: soluble 10 mg/mL, 0.1 M NaOH: insoluble, 2-hydroxypropyl-β-cyclodextrin: insoluble, H2O: insoluble

solubility

H2O: insoluble <0.1% at 20 °C, chloroform: soluble 50 mg/mL, clear, colorless to faintly yellow, 2-propanol: soluble, DMSO: soluble, ethanol: soluble, methanol: soluble, propylene glycol: soluble

solubility

DMSO: soluble >5 mg/mL at 60 °C

originator

Sanofi Aventis

originator

-

originator

AstraZeneca

originator

GlaxoSmithKline

Gene Information

human ... ABCB1(5243), CYP2C8(1558), CYP3A4(1576), HRH1(3269), IL4(3565), IL5(3567), KCNH1(3756), KCNH2(3757)
mouse ... Abcb1a(18671), Abcb1b(18669)
rat ... Hrh1(24448)

Gene Information

human ... EGFR(1956)
mouse ... Egfr(13649)

Gene Information

human ... CYP1A2(1544), EBP(10682), ESR1(2099), ESR2(2100), ESRRA(2101)
rat ... Ar(24208), Esr1(24890)

Gene Information

rat ... Htr1a(24473)


Still not finding the right product?

Explore all of our products under


hcodes

Hazard Classifications

Aquatic Chronic 4

Klasa składowania

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable



Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

Nie widzisz odpowiedniej wersji?

Jeśli potrzebujesz konkretnej wersji, możesz wyszukać konkretny certyfikat według numeru partii lub serii.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów


Produkty

Discover Bioactive Small Molecules for ADME/Tox

Powiązane treści

Product Information Sheet


H Ohtani et al.
The Journal of pharmacy and pharmacology, 51(9), 1059-1063 (1999-10-21)
We examined and compared the inhibitory effects of three non-sedating antihistamines, terfenadine, ebastine, and epinastine, on delayed rectifier potassium current (IK) and transient outward potassium current (Ito) of rat isolated ventricular myocytes, using a patch clamp technique. Terfenadine, ebastine and
Hiroyuki Kusuhara et al.
Drug metabolism and disposition: the biological fate of chemicals, 41(1), 206-213 (2012-11-02)
The effect of rifampicin on the pharmacokinetics of fexofenadine enantiomers was examined in healthy subjects who received fexofenadine alone or with single or multiple doses of rifampicin (600 mg). A single coadministered dose of rifampicin significantly decreased the oral clearance
Naoki Inagaki et al.
European journal of pharmacology, 448(2-3), 175-183 (2002-07-30)
Compound 48/80 induced scratching behavior in BALB/c mice, and the role of mast cell mediators in this behavior was examined. Mouse scratching behavior was detected and evaluated using a new apparatus, MicroAct. Compound 48/80 increased the incidence of scratching behavior



Numer pozycji handlu globalnego

SKUNUMER GTIN
T9652-25G04061832931609
T9652-5G04061837381768

Questions

Reviews

No rating value

Active Filters